Comparison Chart Outlook Therapeutics, Inc.
Stocks
OTLK
US69012T3059
Biotechnology & Medical Research
|
Real-time Estimate
Cboe BZX
02:27:11 18/11/2026 am IST
|
5-day change | 1st Jan Change | ||
| 0.3620 USD | -8.59% |
|
-22.06% | -77.28% |
| 12/10 | Certain Common Stock of Outlook Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 12-OCT-2026. | CI |
| 09/10 | Outlook Therapeutics Names Greg DiPasquale Chief Commercial Officer | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| OUTLOOK THERAPEUTICS, INC. | Other Biotechnology & Medical Research | -9.14% | -22.06% | -77.28% | -79.72% | -99.06% | 9.64Cr |
- Stock Market
- Stocks
- OTLK Stock
- Charts Outlook Therapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
















